Latest Reported Offering
$10,001
Target Amount
$500,000
Maximum Amount
2026-01-16
Deadline
Security Details
Type: Common Stock
Price per share: $0.97
Price set by: The price of the Securities was determined solely by management and bears no relation to traditional measures of valuation such as book value or price-to-earnings rat... [Truncated: see complete discussion in attachment offeringstatement.pdf, question 21.]
Shares offered: 10,310+
Offering Costs
Cash commission: —
Up to 4.9% of amount raised for a successful offering and a listing fee of up to $10,000
Equity compensation: —
None.
Filing history
Form C family — 3 filingsThe reported figures behind Vertical Longevity Pharmaceuticals, Inc.
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Company Information
Legal Status
Corporation
Jurisdiction
DE
Date of Incorporation
2025-03-21
Latest Metrics
Employees1
Total Assets$25.00
Cash on Hand$25.00
Revenues$0.00
Net Income-$18,867
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.